Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2021-10-22 00:00:00 ET · period of report 2021-10-20 · accession 0001567619-21-018613 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-22 | 2021-10-20 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +1,000 | 305.8K | +0.3% | +$37.5K |
| D | 2021-10-22 | 2021-10-20 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -1,000 | 137.0K | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-20 | M | A | 1,000 | $37.46 | 305,839 | D | — | — | |
| 2 | Derivative | Stock Option (Right to buy Common Stock) | 2021-10-20 | M | D | 1,000 | $0.00 | 137,000 | D | $37.46 · 2012-11-08 to 2022-05-07 | 1,000 Common Stock | (F1) Reflects the number of options outstanding after the transactions from this specific stock option grant. |